The utility of ground-glass attenuation score for anticancer treatment-related acute exacerbation of interstitial lung disease among lung cancer patients with interstitial lung disease

Lung Disease ◽

Cancer Patients ◽

Acute Exacerbation ◽

Ground Glass ◽

Lung Cancer Patients ◽

Ground Glass Attenuation ◽

Anticancer Treatment

P2.16-13 Risk Factors of Radiation Pneumonitis in Lung Cancer Patients with Subclinical Interstitial Lung Disease After Thoracic Radiotherapy

Journal of Thoracic Oncology ◽

10.1016/j.jtho.2019.08.1880 ◽

2019 ◽

Vol 14 (10) ◽

pp. S870

Author(s):

F. Li ◽

S. Liang ◽

H. Wu ◽

Y. Xu ◽

M. Chen

Keyword(s):

Risk Factors ◽

Lung Cancer ◽

Lung Disease ◽

Cancer Patients ◽

Radiation Pneumonitis ◽

Thoracic Radiotherapy ◽

MA02.03 Impact of Coexisting Interstitial Lung Disease on Resected Non-Small Cell Lung Cancer Patients

Journal of Thoracic Oncology ◽

10.1016/j.jtho.2019.08.504 ◽

2019 ◽

Vol 14 (10) ◽

pp. S253

Author(s):

J.G. Lee ◽

S.Y. Park ◽

C.Y. Lee ◽

K.S. Narm ◽

S.H. Song

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Lung Disease ◽

Cancer Patients ◽

Cell Lung Cancer ◽

Small Cell ◽

Small Cell Lung ◽

A multicenter single-arm phase II study of nab-paclitaxel/carboplatin for non-small cell lung cancer patients with interstitial lung disease

Annals of Oncology ◽

10.1093/annonc/mdy292.060 ◽

2018 ◽

Vol 29 ◽

pp. viii519-viii520 ◽

Cited By ~ 2

Author(s):

Y. Usui ◽

H. Kenmotsu ◽

K. Mori ◽

A. Ono ◽

K. Yoh ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Lung Disease ◽

Cancer Patients ◽

Phase Ii ◽

Phase Ii Study ◽

Small Cell ◽

Small Cell Lung ◽

Retrospective analysis comparing pulmonary toxicity between S-1 and docetaxel in non-small-cell lung cancer patients with preexisting interstitial lung disease.

Journal of Clinical Oncology ◽

10.1200/jco.2015.33.15_suppl.e19105 ◽

2015 ◽

Vol 33 (15_suppl) ◽

pp. e19105-e19105

Author(s):

Daisuke Akahori ◽

Yuichi Ozawa ◽

Keigo Kouda ◽

Takefumi Abe ◽

Yasunori Enomoto ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Lung Disease ◽

Retrospective Analysis ◽

Cancer Patients ◽

Pulmonary Toxicity ◽

Small Cell ◽

Small Cell Lung ◽

Safety and efficacy of S-1 in combination with carboplatin in non-small cell lung cancer patients with interstitial lung disease: a pilot study

Cancer Chemotherapy and Pharmacology ◽

10.1007/s00280-016-3040-8 ◽

2016 ◽

Vol 77 (6) ◽

pp. 1245-1252 ◽

Cited By ~ 25

Author(s):

Akimasa Sekine ◽

Hiroaki Satoh ◽

Tomohisa Baba ◽

Satoshi Ikeda ◽

Ryo Okuda ◽

...

Keyword(s):

Lung Cancer ◽

Pilot Study ◽

Small Cell Lung Cancer ◽

Lung Disease ◽

Cancer Patients ◽

Small Cell ◽

Small Cell Lung ◽

Safety And Efficacy ◽

The Outcome of Lung Cancer Patients Combined with Interstitial Lung Disease Treated with Palliative Chemotherapy

Annals of Oncology ◽

10.1093/annonc/mdt460.142 ◽

2013 ◽

Vol 24 ◽

pp. ix95

Author(s):

M.K. Choi ◽

M.-J. Ahn ◽

J.-M. Sun ◽

J.-S. Ahn ◽

K. Park

Keyword(s):

Lung Cancer ◽

Lung Disease ◽

Cancer Patients ◽

Palliative Chemotherapy ◽

Gefitinib-Induced Interstitial Lung Disease in Korean Lung Cancer Patients

Cancer Research and Treatment ◽

10.4143/crt.2014.201 ◽

2016 ◽

Vol 48 (1) ◽

pp. 88-97 ◽

Cited By ~ 7

Author(s):

Seung-Hoon Beom ◽

Dong-Wan Kim ◽

Sung Hoon Sim ◽

Bhumsuk Keam ◽

Jin Hyun Park ◽

...

Keyword(s):

Lung Cancer ◽

Lung Disease ◽

Cancer Patients ◽

P8‐87: Clinical study of amrubicin‐induced interstitial lung disease in lung cancer patients with interstitial lung abnormality

Respirology ◽

10.1111/resp.14150_599 ◽

2021 ◽

Vol 26 (S3) ◽

pp. 322-323

Keyword(s):

Lung Cancer ◽

Clinical Study ◽

Lung Disease ◽

Cancer Patients ◽

Pre‐existing interstitial lung disease does not affect prognosis in non‐small cell lung cancer patients with PD‐L1 expression ≥50% on first‐line pembrolizumab

Thoracic Cancer ◽

10.1111/1759-7714.13725 ◽

2020 ◽

Author(s):

Ou Yamaguchi ◽

Kyoichi Kaira ◽

Shun Shinomiya ◽

Atsuto Mouri ◽

Kosuke Hashimoto ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Lung Disease ◽

Cancer Patients ◽

Cell Lung Cancer ◽

Small Cell ◽

Small Cell Lung ◽

First Line ◽

The Ratio KL-6 to SLX in Serum for Prediction of the Occurrence of Drug-Induced Interstitial Lung Disease in Lung Cancer Patients with Idiopathic Interstitial Pneumonias Receiving Chemotherapy

Cancer Investigation ◽

10.3109/07357907.2015.1069832 ◽

2015 ◽

Vol 33 (10) ◽

pp. 516-521 ◽

Cited By ~ 1

Author(s):

Kosuke Kashiwabara ◽

Hiroshi Semba ◽

Shinji Fujii ◽

Shinsuke Tsumura ◽

Ryota Aoki

Keyword(s):

Lung Cancer ◽

Lung Disease ◽

Cancer Patients ◽

Drug Induced ◽

Idiopathic Interstitial Pneumonias ◽